Trial Profile

An Exploratory Phase 2a Study Evaluating the Efficacy and Safety of URO-902 in Subjects With Overactive Bladder and Urge Urinary Incontinence

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 12 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Maxi-K gene therapy (Primary)
Indications Overactive bladder; Urge incontinence
Focus Therapeutic Use
Sponsors Urovant Sciences

Most Recent Events

01 May 2023 Results assessing ling-term efficacy and safety presented at the 118th Annual Meeting of the American Urological Association.
13 Oct 2022 Status changed from active, no longer recruiting to completed.
10 Sep 2022 Interim Results assessing the safety and efficacy of URO 902 in over active bladder , presented at the 52nd Annual Meeting of the International Continence Society

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com